Where the Money Goes

You are here

Home » Love Your Melon

Love Your Melon

Love Your Melon is an apparel brand dedicated to the fight against pediatric cancer. Fifty percent (50%) of net profit from the sale of all Love Your Melon products is given to the Love Your Melon Fund to support our nonprofit partners in the fight against pediatric cancer, create therapeutic experiences, and fund charitable programming initiatives for children and their families battling cancer. To date, we have given over $6.1 million dollars to the fight against pediatric cancer and over 160,000 hats to children battling cancer.

Visit Love Your Melon for more information

Co-Funded Projects

Project Title Institutions Co-Funder(s)
Analysis of Unexpected, Potentially Avoidable Admissions to a Pediatric Oncology Unit Dartmouth College Love Your Melon
Assessing Combinatory Effect of PARP Inhibitor with DNA Damaging Agent on Rhabdomyosarcoma at Single Cell Resolution Harvard University Love Your Melon
Small Molecule Screening for Novel DIPG Inhibitors University of Connecticut Love Your Melon
Combining Glutamine Metabolic Inhibitors with Carboplatin to Target MYC Amplified AT/RT Mississippi State University Love Your Melon
Ion Channels As Molecular Targets in RELA Fusion Driven Ependymoma Skidmore College Love Your Melon
Combination Therapies with CDK4/6 Inhibitors in Pediatric Solid Tumors Harvard College Love Your Melon
Nodal Signaling Promotes Retinoblastoma Invasion and Growth Princeton University Love Your Melon
Targeting Choline Kinase in AT/RT Dickinson College Love Your Melon
Understanding the Effect of IL-15 on Tumor Microenvironment to Enhance Cell-Based Therapies for Pediatric Solid Tumors Rice University Love Your Melon
Knocking out CD38 in T Cell Acute Lymphoblastic Leukemia Love Your Melon

Pages

Featured Hero

Chris Ramirez

Chris loves baseball – he has a history of playing for his high school team and is a longtime fan of the San Francisco Giants. However, when he was in high school, Chris began having strange symptoms. Today, Chris is a three-time survivor of glioblastoma.
Read more »